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Tissue morphogenesis during development is regulated by growth factors and cytokines, and is characterized by constant remodeling of
extracellular matrix (ECM) in response to signaling molecules, for example, growth factors, cytokines, and so forth. Proteoglycans that bind
growth factors are potential regulators of tissue morphogenesis during embryonic development. In this study, we showed that transgenic mice
overexpressing biglycan under the keratocan promoter exhibited exposure keratitis and premature eye opening from noninfectious eyelid
ulceration due to perturbation of eyelid muscle formation and the failure of meibomian gland formation. In addition, in vitro analysis revealed
that biglycan binds to TGF-a, thus interrupting EGFR signaling pathways essential for mesenchymal cell migration induced by eyelid
epithelium. The defects of TGF-a signaling by excess biglycan were further augmented by the interruption of the autocrine or paracrine loop
of the EGFR signaling pathway of HB-EGF expression elicited by TGF-a. These results are consistent with the notion that under
physiological conditions, biglycan secreted by mesenchymal cells serves as a regulatory molecule for the formation of a TGF-a gradient
serving as a morphogen of eyelid morphogenesis.
D 2004 Elsevier Inc. All rights reserved.
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In mammals, eyelid morphogenesis is characterized by
the closure and fusion of the eyelid during development,
which involves two major cellular events: the differentiation
of ocular surface ectoderm to corneal, conjunctival, eyelid
epidermal and glandular (lacrimal and meibomian) epithelia,
and the migration and differentiation of periocular mesen-0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2004.09.022
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E-mail address: Winston.Kao@UC.Edu (W.W.-Y. Kao).chymal cells for the formation of eyelid stroma (Kao and
Liu, 2003). Mouse eyelid formation begins at embryonic
day 12 (E12), with folds of surface ectoderm adjacent to the
developing eye. As it grows, the eyelid fold extends over the
developing cornea, and periocular mesenchymal cells
invade the eyelid stroma. The closure of the eyelid happens
between E15.5 and E16.5, when the tips of the superior and
inferior eyelid epidermis elongate toward the center of the
eye and eventually cover the corneal surface (Findlater et
al., 1993; Harris and Juriloff, 1986). Following epithelial
fusion, the eyelid stroma grows by continued invasion and
proliferation of mesenchymal cells, and a fusion line is
formed between the superior and inferior eyelid epithelium277 (2005) 222–234
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protective barrier over the cornea. The mouse eyelids
remain closed until 12–14 days postnatal. This process
resembles the epithelial sheet migration of dorsal closure
during Drosophila development (Glise and Noselli, 1997;
Zhang et al., 2003), closure of choroid fissure of optic cup
of vertebrates (Kurita et al., 2004; Macdonald and Wilson,
1996), and closure of fusion of chorioamniotic folds over
platypus embryos (Hughes and Hall, 1998) and those of
birds (Gilbert, 2003).
The eyelid serves as a protective barrier for the formation
of the conjunctival sac and the development of the cornea
and lens (Findlater et al., 1993; Harris and Juriloff, 1986). In
normal mouse eye development, the commencement of
eyelid formation coincides with the rapid growth of the
eyeball beginning at E13.5. The formation of lid muscles,
that is, orbicularis oculi, levator palpebral, and tarsal
muscles, is essential for eyelid functions, which provide
the adequate strength required to withstand the pressure
exerted by the rapid growth of the eye. In addition, the tarsal
plate at the end of the tarsal muscles provides the scaffold
for the formation of meibomian glands that derive from
epithelium at the tip of eyelids (Jester et al., 1989). The
meibomian gland is a lipid-secreting gland that plays a
pivotal role for the maintenance of tear film function. For
example, meibomian gland dysfunction resulting from
ectodermal dysplasia in human manifested severe exposure
keratitis (Bron and Tiffany, 1998).
As in many other tissues, eyelid morphogenesis is also
governed by bidirectional mesenchyme–epithelium interac-
tions via growth factors, cytokines, and extracellular matrix
(ECM) components during embryonic development. This is
best illustrated by the eye open at birth phenotype (EOB)
due to impaired epithelial cell migration in mouse strains in
which the genes mediating signaling pathways of EGF,
EGF receptors, and TGF-h superfamily members are
ablated, for example, TGF-a, EGFR, cJun, MEKK 1,
activin hB, and so forth (Li et al., 2003; Luetteke et al.,
1993; Sibilia and Wagner, 1995; Vassalli et al., 1994; Zenz
et al., 2003; Zhang et al., 2003). Thus, it is likely that
genetic perturbations that impair epithelium migration can
potentially cause eyelid malformation. However, it remains
unknown whether mutation of these genes may impair the
functions of periocular mesenchymal cells essential for
eyelid morphogenesis.
Interestingly, failure in eyelid closure caused by sponta-
neous autosomal recessive mutations has been reported in
several mouse strains, such as eye-open-at-birth (eob),
lidgap-Gates (lgGa), open-eyes (oe), and gaping lids (gp)
(Fujii et al., 1995; Juriloff et al., 1996; Stein et al., 1967;
Teramoto et al., 1988). However, in each strain, the mutant
gene responsible for EOB has not been identified (Juriloff et
al., 1996, 2000; Kelton and Rauch, 1968). The obvious
implication is that other molecular and cellular mecha-
nism(s) besides epithelium migration may also be involved
in eyelid morphogenesis. One of the many possibilities is arole for extracellular matrix components in eyelid morpho-
genesis, for example, proteoglycans, collagens, fibronectin,
or laminin.
Proteoglycans belonging to the small leucine-rich
repeat proteoglycan (SLRP) family, for example, decorin,
biglycan, and fibromodulin, have been implicated as
important molecules that bind and modulate the activities
of growth factors and cytokines via their glycosamino-
glycan moieties and core proteins (Kao and Liu, 2002;
Iozzo, 1999; Reed and Iozzo, 2002). Biglycan contains
two side chains of chondroitin sulfate/dermatan sulfate
(CS/DS) glycosaminoglycans and is widely expressed by
fibroblasts of interstitial connective tissues, mesothelial
cells, and epithelial cells (Bianco et al., 1990; Dobra et
al., 2000; Funderburgh et al., 1998). Like other members
of the SLRP family, biglycan serves as a component of
ECM and binds to a variety of other proteins, including
growth factors such as TGF-h, TNF-a, and WISP-1
(Desnoyers et al., 2001; Hausser et al., 1994; Hildebrand
et al., 1994); extracellular matrix proteins such as
collagens I and V, fibronectin (Bidanset et al., 1992;
Schmidt et al., 1987; Schonherr et al., 1995; Wiberg et
al., 2003), and a-amyloid (Snow et al., 1995), apo E and
apo B, a-dystroglycan, and phospholipase A2 type II
(Bowe et al., 2000; Olin et al., 2001; Sartipy et al.,
1998), and serum proteins such as heparin cofactor II
(Fukushima et al., 1993; Hildebrand et al., 1994; Whinna
et al., 1993). These various binding activities may account
for the ability of biglycan to exert diverse functions in
many tissues. For example, it has been suggested that
biglycan may serve as a neurotrophic factor for the
survival of neocortical neurons and participates in the
regulation of neuronal growth, differentiation, and repair
(Junghans et al., 1995; Koops et al., 1996). In addition,
injection of biglycan into the brain apparently promoted
the facilitation of learning (Huston et al., 2000). A recent
study of rat neurons and C6 glioma cells revealed that a
population of biglycan targets to the nucleus and may be
involved in the regulation of neuronal cell division (Liang
et al., 1997). Even though there is no conclusive evidence
available, it is very likely that biglycan may also bind
other growth factors, for example, TGF-a, activin hB,
and so forth. Thus, biglycan is ideally situated to play a
critical role in modulating the functions of growth factors
in situ, and it is, therefore, conceivable that biglycan may
play an important role in morphogenesis and tissue
homeostasis.
We have created transgenic Kera-Bgn mouse lines using
a 3.2-kb keratocan promoter (Liu et al., 2000), in which
migrating periocular mesenchymal cells overexpress bigly-
can during embryonic development. The Kera-Bgn trans-
genic mice exhibited noninfectious eyelid ulceration causing
premature eye opening and severe exposure keratitis. In this
study, we present evidence illustrating that excess biglycan
perturbs the formation of eyelid muscles and the migration
of periocular mesenchymal cells by sequestering TGF-a
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of mouse embryonic development.Materials and methods
Generation of Kera-Bgn transgenic mice
The coding region of mouse biglycan cDNA was
generated by RT-PCR using total RNA isolated from adult
mouse corneas. The first strand cDNA was synthesized by
AMV-reverse-transcriptase with random primers and was
used to prepare the full-length double-stranded cDNAwith a
pair of HindIII linker primers (5V-mBgn: 5V-cccaagcttccac-
catgtgtcccctgtggc-3V and 3V-mBgn: 5V-cccaagcttggcaac-
cactgcctctac-3V). The double-stranded cDNA was cloned
into the HindIII site of the mouse Kera promoter cassette
Kerapr3.2-saBGHpA (Liu et al., 2000). The fidelity of the
biglycan cDNA was verified by sequence analysis. The
Kera3.2-Bgn/BGHpA minigene (5.2 kb) was isolated by
NotI and KpnI digestion and microinjected into mouse-
fertilized eggs by the transgenic core facility of the
Cincinnati Children Hospital Research Foundation. Trans-
genic founders were identified by PCR of tail DNA using a
primer set [Kera9 (+): 5V-ctaacaccagccacaggact-3V and
BGHpA (): 5V-actagaaggcacagtcgagg-3V] flanking the
biglycan cDNA.
All animal procedures were approved by the University
of Cincinnati Animal Care and Use Committee. Timed
mating procedure was used for obtaining mouse embryos at
various developmental stages. Wild-type female mice were
mated with a Kera-Bgn male at 9:00 p.m. and the next
morning at 9:00 a.m. the females were examined for a coital
plug, and 3:00 p.m. in the afternoon was defined as E0.5 of
gestation when the evidence of copulation was detected.
Cesarean-derived embryos at various developmental stages
(E12.5 to 18.5) were genotyped by polymerase chain
reaction with limb or tail DNA.
Northern hybridization
Total RNA was isolated from the corneas of the
embryonic day 18.5 (E18.5) transgenic and wild-type
littermates using TRI-reagentR (Molecular Research Center,
Cincinnati, OH) (Liu et al., 1994), and 10 Ag of each total
RNA was subjected to Northern hybridization with 32P-
labeled cDNA probes of mouse biglycan and glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) as described
previously (Liu et al., 1998).
Histology and immunohistochemistry
The embryos and adult eye tissues were fixed with 4.0%
paraformaldehyde in 0.1 M phosphate buffer, pH 7.4 at 48C
for 24 h, dehydrated, embedded in paraffin, and processed
for histological examination. Histology of the eyes of theembryos was examined by light microscopy after hemato-
xylin and eosin and PAS staining.
For routine immunostaining, 5-Am paraffin sections were
deparaffinized with xylene and rehydrated with graded
ethanol. The sections were stained as described below and
immune reactivity was visualized by Vecta stain ABC kit
(Vector Laboratories), indirect alkaline phosphatase, or
indirect immunofluorescence methods (Vector Laboratories
and Molecular Probes). Primary antibodies used in this
study were against: EGFR, pEGFR (Tyr1173), c-Jun, and
pc-Jun (Santa Cruz, Santa Cruz, CA); TGF-a (Labvision);
a-smooth muscle actin (Sigma); and biglycan (Kresse et al.,
2001). The nuclei were counterstained with methyl green for
immunohistochemistry using alkaline phosphatase conju-
gate, and propidium iodide (PI) or DAPI (Sigma) for
immunofluorescence.
Scanning electron microscopy
The mouse embryos were fixed in 2.5% glutaraldehyde
and 1% tannic acid prepared with 0.1 M phosphate buffer,
pH 7.4. After postfixation with 1% osmic acid, the speci-
mens were dehydrated with routine ethanol series. Follow-
ing treatment with isoamyl acetate, the specimens were
dried by the critical point method and then coated by
platinum in an ion sputtering device. The prepared samples
were examined with a scanning electron microscope (H-
2000, Hitachi) (Zhang et al., 2003).
In situ hybridization
The plasmids of mouse biglycan and TGF-a cDNA
cloned in pBluescript SK+ vector (Stratagene, CA) were
linearized by EcoRI and SalI digestions, and T-7 and T-3
RNA polymerases were used to synthesize digoxigenin-
conjugated antisense and sense riboprobes, respectively
(Roche). Five-micrometer-thick paraffin sections were
deparaffinized and processed for in situ hybridization with
riboprobes of mouse biglycan and TGF-a, as previously
reported (Kao et al., 1996; Saika et al., 2000, 2001). The
sections were dehydrated, mounted, and observed under
light microscopy after methyl green counterstaining.
Cell migration study
Isolation of eyelid epithelium by impression cytology
Filter membranes (2 mm in diameter) were cut from a
DuraporeR filter (pore size 0.45 Am; Millipore). To isolate
epithelium, the membranes were pressed on top of the eyelid
and head skin and immediately removed from the tissues.
The membranes were then used in cell migration assays as
described below (Hayashi et al., 2004).
Preparation of mesenchymal cell culture
The eyelid epithelium of wild-type E13.5 embryos was
removed by impression cytology, and the remaining eyelid
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embryo eyelid stromal tissues were washed in PBS three
times and minced. Tissues were then cultured at 378C in
DMEM supplemented with 10% fetal calf serum in an
incubator equilibrated with 95% air and 5% CO2 for 3 days.
Cells from explant cultures were harvested with trypsin (1
mg/ml) and EDTA (5 mM) treatment, and subcultured on
p100 cell culture dishes (Corning, NY) for three more days.
Fresh medium was added to the culture overnight, prior to
harvesting the cells for migration study. The culture
condition used was unfavorable for the growth of epithelial
cells, thus epithelial cells were absent in the culture as
judged by a phase contrast microscope.
Cell migration assay
To measure cell migration, E13.5 eyelid and head
epithelial tissues were prepared using impression cytology
and were put on the bottom of the well containing 600 Al of
serum-free DMEM (Gibco) of a 24-well plate. Cultured
mesenchymal cells were harvested by treatment with
trypsin-EDTA and washed two times with serum-free
DMEM medium. Cells were suspended at 5  105 cells/
ml in serum-free DMEM. One hundred microliters of cell
suspension was seeded in each TranswellsR (Costar) that
was placed into a 24-well plate containing epithelium.
Blocking antibody (2 Ag/ml) and bovine tendon biglycan (1
or 10 Ag/ml) were included in the culture medium of upperFig. 1. Generation and phenotypes of Kera-Bgn transgenic mice. (A) Diagram of K
by the mouse keratocan promoter cassette Kerapr3.2-saBGHpA. (B) Northern blo
two transgenic mouse lines. (C) Histology of Kera-Bgn mice showing prematu
(arrowheads) at P2. The Kera-Bgn mice suffered severe exposure keratitis at P21 a
of goblet cells (arrowheads), and cornified epithelium (large arrows) at the corneal
transgenic; bpA, bovine growth factor polyadenylation signal; H–E, hematoxylin
SA, splice acceptor site.(TranswellsR) or lower chambers (24-well plate), and
incubated at 378C for 4 h. Cotton swabs were used to
remove cells from the upper surface of the TranswellsR.
The hematoxylin-stained migratory cells at the undersurface
of TranswellsR were counted with an inverted microscope.
Each experimental condition was tested in quadruplicate in
individual experiments, and the number of migratory cells
found on the undersurface of TranswellR membranes of
control experiments consisting of wild-type mesenchymal
cells in the upper chamber and wild-type eyelid epithelial
tissues in the lower chamber was defined as 100% migration
index. Each experiment was repeated four times and
statistical analyses were performed using unpaired t test.
Immune precipitation and Western blot
Pregnant female mice were sacrificed by CO2 asphyx-
iation on E13.5. Fetuses were removed from the uterus and
dissected in PBS, and the limbs were removed for genotype
identification by PCR. Biglycan extracts were prepared with
an alkaline extraction method modified by Bowe et al.
(2000) and Casar et al. (2004). Briefly, 10 eyelid tissues
were homogenized in 50 mM Tris–NaOH, pH 12.0,
containing 250 U/ml of Benzonase nuclease (Novagen,
WI) and protease inhibitor cocktail (Sigma, MO), and
maintained under agitation over night at 48C. Then
homogenates were centrifuged 30 min at 15,000  g inera-Bgn minigene, in which the mouse biglycan cDNA (mBgn) is flanked
t analysis showing biglycan mRNA overexpression in the E18.5 corneas of
re eye open phenotype in Kera-Bgn mice due to noninfectious ulceration
nd are exemplified by the lack of meibomian glands (asterisk), the presence
surface, and vascularized corneal stroma (small arrows). Wt, wild type; Tg,
and eosin staining; H-PAS, hematoxylin and periodic acid Schiff staining;
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Tris–HCl pH 6.0 and added Na acetate pH 8.0 (final
concentration 100 mM), and centrifuged 10 min at 15,000 
g at 48C. The supernatants were incubated with or without
0.5 U/ml chondroitinase ABC at 378C for 1 h. Protein
content in specimens was measured by BCA protein assay
kit (Pierce, IL). For SDS-PAGE, 5 Ag of protein of each
sample was subjected to Western blot analysis as described
below.
To prepare specimens for immune precipitation and
Western blot (IP-Western), eyelid tissues were lysed in
buffer solutions containing 50 mM Tris–HCl (pH 7.4), 250
mM NaCl, 25 mM NaF, 5 mM EDTA, 1 mM PMSF, 0.1%
Nonidet P-40 in the presence of a protease inhibitor cocktail
(Sigma) at 48C for 24 h. Tissue lysates were clarified by
centrifugation at 14,000 rpm, 48C for 10 min. To remove
nonspecific binding of protein to protein G-Sepharose,
lysates were incubated with protein G-Sepharose (Amer-
sham Biosciences) for 1 h. Slurries were spun down, and an
aliquot of the supernatant was incubated with rabbit anti-
TGFa, anti-TGFh, anti-EGF, anti-activinhB, anti-HB-EGF,
or anti-EGFR antibodies at 1 Ag/ml IgG (Santa Cruz) at 48C
overnight. The antigen–antibodies complexes were precipi-
tated with protein G-Sepharose conjugate. Immunoprecipi-
tated proteins were electrophoresed on SDS-PAGE and
blotted onto polyvinylidene difluoride membrane (Immobi-
lon-P; Millipore Corp.). Immunoblots were treated withFig. 2. Eyelid development in wild type and Kera-Bgn transgenic mice. (A) Horizo
mouse eye (H–E stain). Eyelid stroma of Kera-Bgn (Tg) mice is thinner and has fe
fused between E15.5 and E16.5. In Kera-Bgn mice, the eyelid closure is delayed a
development. Delay of eyelid closure was seen in Kera-Bgn (Tg) mice (E14.5 to E
epithelium (arrowheads) is irregular just before eyelid closure (E15.5). Ulceration o
fused eyelids are seen in wild-type (Wt) mice (arrows).chondroitinase ABC, blocked with 5% dry milk in TBST
(0.1% Triton X-100, 0.15 M NaCl, 50 mM Tris–HCl, pH
7.4), and probed with anti-biglycan antibody. After incuba-
tion with goat anti-rabbit IgG HRP conjugate, immunoblots
were developed by the enhanced chemiluminescence system
(Amersham Biosciences). Supernatant of eyelid homoge-
nate in 50 mM Tris–HCl (pH 7.4), 150 mM NaCl, 10 mM
EDTA, 0.5% sodium deoxycholate, 1 mM PMSF, 1%
Nonidet P-40, 0.1% SDS, protease inhibitor cocktail was
subjected to Western blot analysis to identify growth factors,
receptors, and c-Jun as previously described (Saika et al.,
2000).
Confocal microscopy
Developing embryos were evaluated at days 15.0, 15.5,
17.0, and 17.5 of gestation. Samples were fixed in 4%
paraformaldehyde in PBS, and developing eyes and
surrounding lids removed and stained with the following
combinations of probes: (1) FITC-conjugated mouse anti-
a-smooth muscle actin (a-SMA) and rhodamine phalloidin,
or (2) FITC-conjugated phalloidin and propidium iodide.
Samples were then mounted on mylar bottom plates (25 Am
thick) (Invitrogen) or further dissected to include just the
developing lid tissues and mounted on glass slides with
PBS/glycerol (1:1). Samples were viewed using a Leica
SP2 confocal microscope with argon/krypton and helium/ntal (E13.0 and E13.5) and coronal (E14.5 to E16.5) sections of developing
wer cells compared to wild-type (Wt) littermates. In wild-type mice, eyelids
s compared to wild type. (B) Scanning electron microscopy of mouse eyelid
16.5). The elongation direction of the leading edge of the Kera-Bgn mouse
ccurs in the eyelid fusion area (*) of E17.5 Kera-Bgn mice, whereas tightly
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543, and 633 nm. Three-dimensional data sets were
collected from each sample and reconstructed using the
Leica three-dimensional software package including max-
imum intensity projections for identifying localization of
actin and a-SMA.Fig. 3. Development of eyelid orbicularis oculi, and levator palpebrae and
tarsal muscles. (A) Confocal three-dimensional maximum intensity
projections of the outer layers (epidermal side) of the developing orbicularis
oculi from wild type (Wt) and Kera-Bgn (Tg) mice at E15.5 and E17.0.
Lids are stained by anti-a-SMA staining (green) and phalloidin (red).
Developing orbicularis oculi muscle shows continuous anti-a-SMA
staining circumferentially around the eyelids and presumptive tarsal plate
(double headed arrows) in wild type (Wt). At the same developmental
stage, Kera-Bgn mice showed muscle development limited to the medial
and lateral (top right panel, arrow) aspects of the eyelids. This
developmental stage was approximately 12 h behind that detected for the
wild-type (Wt) lid. The presumptive tarsal plate never appeared to become
compacted, and the area is covered by remnant epidermal epithelium
(asterisk). (B) Confocal three-dimensional maximum intensity projections
of the outer layers (top panels, palpebral side) and immunofluorescent
staining (bottom panels) of the developing eyelid from wild type (Wt) and
Kera-Bgn (Tg) mice at E17.5. In wild-type mice, the tarsal muscle bundles
run vertically toward the lid tip (top left panel, arrows; bottom left panel
arrowheads). In Kera-Bgn (Tg) mice, the lid margins never fuse (top right
panel, asterisk) with breaks in the developing orbicularis muscle fibers (top
right panel, arrow). Development of the tarsal muscles is also delayed and
fragmented (right bottom panel, arrowheads).Results
Phenotype of Kera-Bgn transgenic mice
A 3.2-kb murine keratocan promoter was used to create
transgenic mice that overexpress biglycan by migrating
periocular mesenchymal cells during eyelid development
(Liu et al., 2000). Two independent transgenic Kera-Bgn
mouse lines (C65-8 and C65-14) were obtained via micro-
injection of fertilized mouse eggs with a minigene contain-
ing a 3.2-kb keratocan promoter and a mouse biglycan
cDNA (Fig. 1A). Due to the exposure keratitis observed in
postnatal transgenic mice (Fig. 1C), embryonic corneas
were used to determine the expression level of biglycan in
corneas by Northern hybridization. As shown in Fig. 1B, at
E18.5 the transgenic mice have a higher level of biglycan
mRNA in the cornea than that of wild-type littermates. Both
transgenic lines had the same phenotype of premature eye
opening due to noninfectious ulceration at postnatal day 1
(P1) or P2 and suffered severe exposure keratitis as they
grew older (Fig. 1C). Histology examinations revealed that
the transgenic mice at P21 exhibited the lack of meibomian
glands, malformation of the tarsal plate, epithelial hyper-
plasia with the formation of a cornified envelope and the
presence of goblet cells on the peripheral corneal surface,
and vascularization and invasion of inflammatory cells in
the corneal stroma, suggesting conjunctivalization of the
corneal surface.
To examine whether the phenotype observed is a primary
defect caused by excess biglycan, we checked the eyelid
development of transgenic mouse strains by histology and
scanning electron microscopy. In Kera-Bgn mice, eyelid
malformation started at E13.5 (Fig. 2A). Kera-Bgn trans-
genic mouse eyelid closure was delayed by about half a day
in comparison to wild-type littermates. After eyelid closure,
the eyelid stroma was thinner and there were fewer stromal
cells than in wild-type littermates. By scanning electron
microscopy study, the elongation at the leading edge of the
Kera-Bgn mice epithelium was irregular compared to the
wild-type littermates. Ulceration of the eyelid fusion area
was already apparent in E17.5 Kera-Bgn mice (Fig. 2B).
During embryonic development, Kera-Bgn mice showed
normal expression patterns of Krt12 (keratin 12 gene) by
corneal epithelium and Krt1/Krt10 by eyelid epidermal
epithelium similar to that of wild-type mice (data not
shown). This observation is consistent with the notion that
changes of corneal surface observed in postnatal transgenic
mice are secondary to the pathogenesis of exposure keratitis.
Fig. 4. Expression of biglycan determined by Western blot and in situ
hybridization. (A) Protein extracts of eyelids from E13.5 and E14.5 wild
type (Wt) and Kera-Bgn (Tg) mice were treated with and without
chondroitinase ABC (0.5 unit/ml) prior to Western blot analysis with rabbit
anti-biglycan antibodies. Actin determined by Western analysis was used to
normalize the amounts of proteins applied to the gels. The biglycan existed
as a heterogeneous CS/DS proteoglycan with molecular weights ranging
from 46 kDa to greater than 250 kDa. The high molecular proteins reacted
by the antibodies were digested by the enzyme and migrate as the 46 kDa
biglycan core protein. (B) In situ hybridization reveals that biglycan mRNA
was expressed by migrating mesenchymal cells of eyelid from wild-type
(Wt) mice. In Kera-Bgn (Tg) mice, migrating mesenchymal cells (arrow-
heads) expressing biglycan accumulate under the epithelium adjacent to the
palpebral side of conjunctiva at the tip of the lid from E13.5 through E14.5,
with an interrupted pattern throughout the eyelid stroma as compared to
wild-type (Wt) mice at E14.5.
Y. Hayashi et al. / Developmental Biology 277 (2005) 222–234228Eyelid muscle development
As shown in Fig. 1C, the Kera-Bgn mice at P21
exhibited lack of the tarsal plate. To examine whether
excess biglycan impairs the formation of eyelid muscles, for
example, orbicularis oculi, levator palpebrae, and tarsal
muscles, confocal microscopy using Phalloidin Rhodamine
(F-actin) and anti-a-smooth muscle actin (a-SMA) anti-
bodies was performed during the development of wild type
and Kera-Bgn mice.
Wild-type mouse
Early development of orbicularis oculi muscles (green)
was detected at the lateral and medial margins of the lids by
anti-a-SMA staining. By E15.5 (Fig. 3A, top-left), rapid
development of the orbicularis oculi muscles was noted with
muscle fibers extending from the lateral to medial insertions
of the muscle to completely circumscribe the eyelid
margins. Muscle development appeared to parallel lid
closure and the formation of presumptive tarsal plate
(double headed arrows) that excluded any developing
muscles fibers. Closure of the lid margins at E17.0 was
characterized by prominent development of the orbicularis
oculi muscle with muscle fibers running almost vertically
alongside of the presumptive tarsal plate (Fig. 3A, bottom-
left, arrowheads). At the time of eyelid fusion, prominent
muscle bundles from the orbicularis oculi ran directly along
the presumptive tarsal plate, vertically from the lateral to the
medial insertion. At E17.5, development of the levator
palpebrae and tarsal muscles underlying the palpebral
conjunctiva was detected and characterized by anti-a-
SMA staining of developing muscles running vertically
across the orbicularis oculi toward the developing tarsal
plate (Fig. 3B, top-left, arrows and bottom left, arrowheads).
Kera-Bgn transgenic mouse
Initial development of the orbicularis oculi muscle at the
medial and lateral margins of the eyelid was first detected at
E15.5 with staining by anti-a-SMA (Fig. 3A, top-right).
Staining of the developing muscle was noted to be at least
12 h behind that observed for wild-type littermates. a-SMA-
stained muscle bundles failed to develop circumferentially
around the developing eyelid margin (Fig. 3A, bottom-
right). Additionally, the presumptive tarsal plate never
appeared to become compacted and appeared much wider
than that observed in lids from wild-type mice. It should be
noted that muscle bundles never developed running parallel
to the presumptive tarsal plate and that the margins of the
developing lid mesenchyme never fused but remained
separated by epithelium covering the surface of the eye
(Fig. 3A, bottom-right, asterisk). Evaluation from the
palpebral conjunctival side of the lid also showed prominent
interruption in the developing orbicularis oculi muscle
bundle (Fig. 3B, top-right, arrow), and the development of
the levator palpebrae and tarsal muscles was delayed and
showed more irregular development of muscle fibers (Fig.3B, top-right; bottom-right, arrowheads) compared to the
wild-type lid (Fig. 3B, top left, arrows; bottom left,
arrowheads).
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Western blot analysis was used to determine whether there
was more biglycan present in the eyelid of transgenic mice.
Biglycan extracted from wild type and transgenic mice was
treated with or without chondroitinase ABC prior to PAGE-
SDS. As shown in Fig. 4A, more biglycan was recovered
from tissue extracts prepared from transgenic mice than the
wild type at E13.5 and E14.5. The biglycan core protein is
detected in molecular size ranges from about 46 kDa to larger
than 250 kDa. The high molecular weight bands are sensitive
to chondroitinase ABC digestion, indicating the biglycan
exists as a CS/DS-proteoglycan having various degrees of
posttranslational modifications.
In situ hybridization reveals that in wild-type mice,
mesenchymal cells expressing biglycan first appeared at
the base of the nasal eyelid fold at E13.5 and invaded
into the eyelid stroma at E14.0 and spread along a path
from the base to the tip of eyelid stroma at E14.5 (Fig.
4B, left panels). In Kera-Bgn mice, the migrating
mesenchymal cells expressing biglycan also appeared at
the base of the lid (Fig. 4B, top right, arrow heads).
Interestingly, in contrast to wild-type mice, in Kera-Bgn
mice stronger hybridization signals were detected, sug-Fig. 5. Mesenchymal cell migration induced by eyelid epithelium. (A) DAPI stainin
left). Primary eyelid stromal cells derived from explant culture of E13.5 eyelid at
the TranswellR membrane when eyelid epithelium is placed in the lower chamber
absence of eyelid epithelium (bottom left). (B) Bovine biglycan (1 and 10 Ag/ml)
whereas biglycan added to the upper chamber does not perturb cell migration. (C) A
the lower chamber and EGF receptor antibodies to the upper chamber significantly
anti-EGF, and anti-activin hB in the upper or EGFR in the lower chamber.gesting more mesenchymal cells or the mesenchymal
cells expressing a higher level of biglycan mRNA
appeared concentrated at the eyelid tip at E14.0 (Fig.
4B, middle-right), and at the tip and base of the eyelid at
E14.5 (Fig. 4B, bottom right). These observations of the
distribution of biglycan-expressing cells in transgenic
mice implicate that the initial wave of mesenchymal cell
migration is not compromised, but the continued mesen-
chymal cell migration is perturbed by excess biglycan
expression during development.
As shown in Fig. 2, the eyelids of Kera-Bgn mice
had thinner stroma and fewer cells as compared to wild-
type mice, we investigated the possibility that this
morphological abnormality in the presence of excess
biglycan could derive from decreased cell proliferation,
increased apoptosis, or impaired mesenchymal cell
migration. To examine these three hypotheses, we first
determined cell proliferation activities by BrdU incorpo-
ration and apoptosis by TUNEL assay, and found there
was no difference in BrdU incorporation and cell
apoptosis between wild type and Kera-Bgn mice (data
not shown). Thus, the eyelid thinning and decrease of
eyelid stromal cells may be due to the perturbation of
mesenchymal cell migration rather than altered cell
proliferation and apoptosis in transgenic mice.g of impression cytology taken from E13.5 wild-type eyelid epithelium (top
day 3 (top right). Cultured eyelid stromal mesenchymal cells migrate across
(bottom right). Few mesenchymal cells migrate across the membrane in the
added to the lower chamber suppresses eyelid mesenchymal cell migration,
ddition of neutralizing antibodies (1 Ag/ml) against TGF-a or activin hB to
suppresses mesenchymal cell migration, but not anti-TGF-a, anti-TGF-hs,
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To examine the possibility that excess biglycan might
perturb cell migration in developing eyelids, a two-
chamber culture system was designed in which eyelid
epithelium obtained by impression cytology was placed in
the lower chamber, and eyelid mesenchymal cells were
seeded on a TranswellR membrane in the upper chamber.
The epithelium and mesenchymal cells were co-cultured
at 378C in a CO2 incubator for 4 h. The number of
mesenchymal cells that migrated toward the epithelium
and across the trans-membrane pores was determined as
described in Materials and methods. When eyelid epithe-
lial tissues were used, many eyelid mesenchymal cells
migrated to the opposite side of the TranswellR membrane
as shown in Fig. 5A. In the first series of experiments, the
eyelid epithelium was prepared from mouse embryos at
different gestations E13.5, 14.5, and 15.5 by impression
cytology. It was found that the eyelid epithelium from E13.5
embryos produced the highest chemoattractive activity on
mesenchymal cells (data not shown). E13.5 embryos were
then used in all the following experiments.
To examine whether biglycan might impair mesenchy-
mal cell migration, biglycan (1 and 10 Ag/ml) was
included in the culture medium of either the lower or
upper chamber. Fig. 5B demonstrates that biglycan added
in the lower chamber containing eyelid epithelium
effectively blocked the migration of mesenchymal cells
from the upper chamber toward the epithelium placed in
the lower chamber, whereas biglycan added in the upper
chamber did not perturb mesenchymal cell migration. This
observation is consistent with the notion that biglycan may
bind to and abolish the activity of chemoattractive factor(s)
secreted by the eyelid epithelium.
It has been demonstrated that the perturbation of
EGFR and activin hB signaling pathways leads to the
eye open phenotype in mouse strains. Thus, we tested theFig. 6. Binding of biglycan to TGF-a. E13.5 eyelid tissue extracts from wild typ
activin hB, EGF, HB-EGF, or EGFR antibodies. The antigen–antibody complexe
Western blot with anti-biglycan antibodies. Only use of the anti-TGF-a antibod
weights between 30 and 50 kDa represents the IgG of the primary antibodies.possibility that biglycan might bind to and sequester
growth factors, for example, TGF-a, EGF, TGF-h, and
activin hB, secreted by eyelid epithelium. Neutralizing
antibodies to such growth factors were included in the
culture medium. As shown in Fig. 5C, addition of anti-
TGF-a antibodies, but not anti-EGF or anti-TGF-h
antibodies, in the lower chamber strongly inhibits cell
migration induced by E13.5 wild-type epithelium. Addi-
tion of anti-activin hB antibodies produced a moderate
inhibition of cell migration. Neutralizing antibodies of
TGF-a, TGF-h, EGF, and activin hB present in the
upper chamber did not perturb mesenchymal cell migra-
tion. The presence of neutralizing antibodies against
EGFR in the upper chamber inhibits eyelid stromal cell
migration, suggesting that eyelid mesenchymal cell
migration is mediated via the TGF-a/EGFR signaling
pathway.
Detection of Bgn-TGF-a complex by immune
precipitation–Western blot analysis
Asmentioned above, excess biglycan may sequester TGF-
a and abolish the TGF-a-induced periocular mesenchymal
cell migration by disrupting the gradient of the growth factor
in eyelid stroma morphogenesis during embryonic develop-
ment of Kera-Bgn mice. To verify the existence of such a
growth factor–biglycan complex in developing eyelids,
proteins were extracted from eyelids of E13.5 mouse
embryos and incubated with antibodies against TGF-a,
TGF-h, activin hB, EGF, HB-EGF, and EGFR. The potential
antigen–antibody complexes were precipitated by protein G-
Sepharose conjugates and subjected to Western blot analysis
with rabbit anti-biglycan antibodies. As shown in Fig. 6, only
anti-TGF-a antibodies co-precipitated biglycan from eyelid
extracts, but not anti-activin hB, TGF-h, EGFR, EGF, or HB-
EGF antibodies. The results support the suggestion that
biglycan does bind to TGF-a.e (Wt) and Kera-Bgn (Tg) mice were incubated with anti-TGF-a, TGF-h,
s were precipitated with protein G-Sepharose conjugates and subjected to
y co-precipitated TGF-a and biglycan. The reactive material at molecular
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The results described above indicate that excess
biglycan can sequester TGF-a and block the growth
factor from serving as a chemoattractant for mesenchymal
cell migration during eyelid morphogenesis. Thus, it is
predictable that overexpression of biglycan by migrating
periocular mesenchymal cells may alter the distribution of
TGF-a in developing eyelid and consequently perturb the
signaling pathways, for example, activation of EGFR and
AP 1 transcription factors. To examine these possibilities,
we examined expression levels and localizations of TGF-
a, EGFR and phosphorylated EGFR (pEGFR), HB-EGF,
and cJun and phosphorylated cJun (pcJun) in the
developing eyelids of E13.5 Kera-Bgn and wild-type
mice. Western blot analysis showed similar levels of
active TGF-a and EGFR; an increase of total TGF-a;Fig. 7. Expression of TGF-a, EGF, and HB-EGF, and activation of EGFR and cJun
of TGF-a, EGF, HB-EGF, EGFR, pEGFR, cJun, and pcJun of eyelid extracts from
phosphorylation of EGFR and cJun in Kera-Bgn (Tg) mice. (B) In situ hybridizatio
wild-type (Wt) and Kera-Bgn (Tg) eyelid. Immunohistochemistry shows TGF-a d
epithelium of Kera-Bgn (Tg) mice, but it is more evenly distributed along the s
downregulated in the eyelids of Kera-Bgn mice (counter stained with propidium
mesenchymal cells and epidermal epithelium of E13.5 wild-type (Wt) eyelid, where
(D) cJun and pcJun expression (green) in migrating mesenchymal cells. The tissue
E13.5 by both wild-type (Wt) and Kera-Bgn (Tg) eyelid mesenchymal cells. Fewe
littermates. (E) Diagrams illustrating the EGFR signaling mediated by TGF-a dur
presence of excess biglycan in transgenic mice sequesters TGF-a and consequent
HB-EGF and impairs mesenchymal cell migration.decreases of cJun and HB-EGF; and reduction of pEGFR
in Kera-Bgn mice compared to wild-type mice (Fig. 7A).
In situ hybridization revealed that TGF-a was highly
expressed by epidermal epithelium of eyelid and migrat-
ing periocular mesenchymal cells of both Kera-Bgn and
wild-type mice (Fig. 7B). However, immunohistochemis-
try with anti-TGF-a indicates that in transgenic mice the
growth factor was unevenly distributed and more
abundant in the upper one-third portion of the eyelid
adjacent to epidermis, whereas in wild-type mice the
growth factor was widely distributed and extended
through more than two-thirds of the developing eyelid
at E13.5. This pattern of TGF-a distribution is consistent
with the overexpression of biglycan by mesenchymal
cells of Kera-Bgn mice, as shown in Fig. 4. Furthermore,
the expression of HB-EGF was suppressed (Fig. 7B) and
the activation of EGFR (phosphorylation) was down-
regulated in the eyelids of Kera-Bgn mice (Fig. 7C). Asduring eyelid morphogenesis of Kera-Bgn mice. (A) Western blot analysis
E13.5 embryos shows downregulated expression of HB-EGF and cJun, and
n detects TGF-a mRNA in epithelium and migrating mesenchymal cells of
istribution is limited to the upper one-third of eyelid stroma adjacent to the
troma of wild-type (Wt) mice. The expression of HB-EGF (green) is also
iodide, red). (C) EGFR (red) and pEGFR (green) are detected in migrating
as lower pEGFR positive signals are observed in Kera-Bgn (Tg) littermates.
sections are counterstained with propidium iodide (red). cJun is expressed at
r cells express pcJun in Kera-Bgn (Tg) eyelid stroma compared to wild-type
ing eyelid morphogenesis in wild-type (Wt) and Kera-Bgn (Tg) mice. The
ly perturbs the autocrine or paracrine loop of EGFR signaling pathways via
Y. Hayashi et al. / Developmental Biology 277 (2005) 222–234232shown in Fig. 7D, excess biglycan caused a slight
decrease of c-Jun protein, but strongly inhibited the
activation of c-Jun as shown by a decrease of pcJun in
the eyelids of Kera-Bgn mice.Discussion
In the present studies, we have characterized the Kera-
Bgn transgenic mice that exhibit premature eye opening and
severe exposure keratitis characterized by epithelial hyper-
plasia and the formation of a cornified envelope at the
corneal surface. These defects are secondary to the mal-
development of eyelids with thin stroma, lack of tarsal
plates and meibomian glands, and perturbed maturation of
lid orbicularis oculi, and levator palpebrae and tarsal
muscles. In contrast in wild-type mice, compaction of the
presumptive tarsal plate directly coincided with the develop-
ment of muscle fibers running parallel to the presumptive
tarsal plate, presumably associated with the developing pars
palpebralis portion of the orbicularis oculi muscle that
inserts into the medial ligament. These findings taken
together suggest that development of lid and associated lid
muscles plays a critical role in lid closure and fusion.
Furthermore, excessive biglycan expression appears to
interfere with critical EGFR signal transduction events
involving TGF-a.
Role of lid muscles in eyelid morphogenesis
Tension within the muscle exerted during development
might provide mechanical forces that keep the lids closed
during development. Additionally, it should be noted that
the eye extends out beyond the surface of the lids early in
development. As the muscles develop, contraction of the
muscle would tend to pull the lids across the eye and help
push the eye farther back into the orbit.
Data concerning the Kera-Bgn mice suggest that eyelid
open at birth may be related to a major defect in the
development of eyelid muscles. Failure of the normal
development of this muscle might lead to a failure in the
fusion of the lids due to the mal-approximation of the
mesenchymal portion of the developing eyelids. As the eye
grows, the failure of the muscles to align parallel to the
tarsal plate might lead to structural failure as the growing
eyeball pushes forward. At some point during development,
the eyeball would then push open the lids resulting in the
eyelid open at birth phenotype. The malformation of tarsal
muscle in Kera-Bgn mice fails to provide a scaffold for the
formation of meibomian glands. The lack of meibomian
glands contributes to the severe exposure keratitis observed
in Kera-Bgn mice resembling the pathogenesis of human
diseases of meibomian glands dysfunction from ectodermal
dysplasia (Bron and Tiffany, 1998).
However, the molecular and cellular mechanism(s)
whereby excess biglycan impairs lid muscle formationremains unknown. During avian eye development, it has
been suggested that eyelid muscles may be also derived
from periocular mesenchymal cells that give rise to stromal
cells of many ocular tissues, for example, cornea, iris, ciliary
body, and eyelids (Noden, 1986). It remains unknown
whether malformation of orbicularis oculi, levator palpe-
brae, and tarsal muscles of Kera-Bgn mice is due to
impaired mesenchymal cell migration or perturbed differ-
entiation of mesenchymal cells, or both. It has been
demonstrated that biglycan binds to a-dystroglycan and
that in muscle biglycan is detected at both synaptic and
nonsynaptic regions. Furthermore, biglycan expression is
upregulated in muscle from dystrophic mdx mice (Bowe et
al., 2000). Thus, our observation of malformation of lid
muscles in transgenic mice is consistent with the notion that
upregulated biglycan expression may account for the
pathogenesis of some muscular dystrophies. Further studies
are needed to elucidate the molecular and cellular mecha-
nism(s) of eyelid muscle development, and whether the mal-
development of eyelid muscles is directly caused or is
mediated by the perturbation of EGFR signaling pathways
due to excess biglycan.
Migration of periocular mesenchymal cells during eyelid
morphogenesis
Epithelium sheet migration induced by growth factors or
cytokines plays a pivotal role in tissue morphogenesis
during embryonic development. For example, TGF-h
signaling is essential for dorsal closure in Drosophila (Glise
and Noselli, 1997). Genetic alterations in many knockout
and transgenic mouse strains that exhibit an eye open at
birth phenotype are characterized by impaired epithelium
sheet migration (Carroll et al., 1998; Li et al., 2003;
Luetteke et al., 1993; Sibilia and Wagner, 1995; Vassalli
et al., 1994; Zenz et al., 2003; Zhang et al., 2003). Many
signal transduction pathways, including activin hB, TGF-a/
EGFR, MEKK1, and c-Jun, are involved in eyelid closure.
In addition, mutations of molecules mediating cell migra-
tion, for example, integrins, fibronectin, and so forth, are
also exemplified by the eye open at birth phenotype. It has
been demonstrated that mutation of these genes also causes
defective cell migration of cultured epithelial cells in vitro.
In the present studies, our data demonstrate for the first
time that TGF-a signaling also plays an important role in
regulating the migration of periocular mesenchymal cells
into the eyelid stroma during development. Mesenchymal
cell migration also appears to be independent of TGF-h
signal transduction, as shown in our previous studies of
TGF-h knockout mice that do not exhibit mal-development
of the eyelid (Saika et al., 2001). However, inhibition of cell
migration by activin hB-neutralizing antibodies is consistent
with the eye open at birth phenotype observed in activin hB
knockout mice (Vassalli et al., 1994), suggesting that activin
hB may also serve as a chemoattractant to periocular
mesenchymal cells during eyelid morphogenesis.
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Interestingly, the present studies provide evidence that
EGFR signaling pathways play a pivotal role in periocular
mesenchymal cell migration. The disruption of the TGF-a
gradient necessary for mesenchymal cell migration by
excess biglycan is accompanied by diminished phosphor-
ylation of EGFR and cJun and the suppression of HB-EGF
(Fig. 7). Thus, excess biglycan perturbs the autocrine or
paracrine loops of the EGFR signaling pathways required
for normal lid morphogenesis (Fig. 7E). EGF receptor
signaling is essential for eyelid morphogenesis as evidenced
by spontaneous mutations or knockout mouse strains in
which this signaling pathway is interrupted. For example,
ablation and spontaneous mutation of TGF-a and ablation
of EGFR elicit the eye open at birth phenotype (Luetteke et
al., 1993; Mann et al., 1993; Reneker et al., 1995). The
TGF-a signaling is probably mediated by MAP kinase
pathways. Recently, it has been shown that conditional
ablation of cJun in the epidermis leads to the eye open at
birth phenotype. In vitro analysis using cultured epithelial
cells revealed that the lack of these gene products is
associated with impaired epithelial cell migration and
interruption of the autocrine and paracrine loops of EGFR
signaling pathways (Li et al., 2003; Zenz et al., 2003). It is
of interest to note that ablation of MEKK 1 also elicits an
eye open at birth phenotype. In vitro examination of
cultured epithelial cells isolated from skin of mice lacking
MEKK 1 kinase activities indicates that MEKK 1 mediates
the activin hB signaling pathways (Zhang et al., 2003).
In summary in the present studies, we have demonstrated
for the first time that excess biglycan perturbs eyelid muscle
formation that can in part explain the eye open at birth
phenotype of Kera-Bgn mice. Also, excess biglycan in the
eyelid stroma of transgenic mice sequesters TGF-a and
disrupts the formation of the TGF-a gradient that is
necessary for guiding mesenchymal cell migration and
consequently interrupts the EGFR signaling loops necessary
for eyelid morphogenesis (Fig. 7E). Thus, it is intriguing to
suggest that the ability of biglycan to bind TGF-a allows
this CS/DS-proteoglycan to serve as a regulatory molecule
for the formation of a TGF-a gradient in eyelid morpho-
genesis during normal embryonic development.Acknowledgments
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